News

Launch of Evinco Therapeutics: A pioneering biotech company advancing immune therapies for Alzheimer’s disease

Launch of Evinco Therapeutics: A pioneering biotech company advancing immune therapies for Alzheimer’s disease

Evinco Therapeutics is an Australian start-up on a mission to transform the treatment of Alzheimer’s disease and other neuroinflammatory conditions

Melbourne, Australia, 4 December 2025 – An exciting chapter in medical innovation begins today with the official launch of Evinco Therapeutics Pty Ltd (“Evinco” or “Company”), a Melbourne-based biotechnology company developing advanced immune-based therapies for […]

Christine Filippis2025-12-04T15:17:50+11:00December 4th, 2025|

Cartherics appoints Dr Ian Nisbet as Chief Executive Officer

Cartherics appoints Dr Ian Nisbet as Chief Executive Officer

Dr Ian Nisbet appointed as Chief Executive Officer
Prof Alan Trounson AO will move into the role of Deputy Chair of the Board

Melbourne, Australia, 28 November 2025 –  Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune cell therapies focusing on high-impact women’s diseases, with lead programs in ovarian […]

Christine Filippis2025-11-28T10:15:10+11:00November 28th, 2025|

Cartherics to present at ANZSEV 2025

Cartherics to present at ANZSEV 2025

Cartherics is pleased to announce that it will be presenting at the 8th Australian and New Zealand Society for Extracellular Vesicles (ANZSEV) 2025 Conference in Wellington, New Zealand. ANZSEV 2025 will showcase advances in the field across EVs and biological nanoparticles – their role in cell biology, advances in technologies for their purification and […]

Christine Filippis2025-11-17T11:25:49+11:00November 17th, 2025|

Cartherics achieves clean room certification to support clinical-grade cell therapy manufacturing

Cartherics achieves clean room certification to support clinical-grade cell therapy manufacturing

Cartherics is proud to announce the successful certification of our new clean room facility, marking a significant milestone in our journey toward delivering off-the-shelf cell therapies for cancer and endometriosis.

This milestone builds on the recent unveiling of our cleanroom facility, as announced here, and reflects our continued progress in […]

Christine Filippis2025-10-27T15:16:06+11:00October 27th, 2025|

Cartherics hosts Frocktober afternoon tea for ovarian cancer awareness

Cartherics hosts Frocktober afternoon tea for ovarian cancer awareness

Today, Cartherics proudly hosted a Frocktober Afternoon Tea in support of ovarian cancer awareness and research. Frocktober is a meaningful initiative that encourages us to go the extra style mile – turning heads, starting conversations, and raising vital funds for ovarian cancer research.

We were honoured to welcome Robin Penty, CEO of the Ovarian Cancer Research […]

Christine Filippis2025-10-16T12:08:59+11:00October 15th, 2025|

The Next Generation of Cell Therapy with Cartherics’ COO Dr. Ian Nisbet

The Next Generation of Cell Therapy with Cartherics’ COO Dr. Ian Nisbet

Cartherics’ COO, Dr Ian Nisbet recently joined Xtalks’ Life Science Podcast to discuss Cartherics’ vision for next generation cell therapies.

He discussed how Cartherics’ platform is building an effectively unlimited supply of CAR NK cells and exploring treatments for underserved conditions like cancer and endometriosis. Dr Nisbet also reflects on his biotech leadership […]

Christine Filippis2025-10-15T10:36:51+11:00October 1st, 2025|

Cartherics Wins ‘Most Promising iPSC Therapy Pipeline in APAC’ at Asia Pacific Cell & Gene Therapy Excellence Awards

Cartherics Wins ‘Most Promising iPSC Therapy Pipeline in APAC’ at Asia Pacific Cell & Gene Therapy Excellence Awards

Melbourne, Australia, 11 September 2025 –  Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune cell therapies focusing on high-impact women’s diseases, with lead programs in ovarian cancer and endometriosis, is proud to announce that it has been named ‘Most Promising iPSC Therapy Pipeline in APAC’ in the Asia Pacific Cell […]

Christine Filippis2025-09-12T12:21:47+10:00September 11th, 2025|

Cartherics CEO Prof. Alan Trounson featured on 10News+

Cartherics CEO Prof. Alan Trounson featured on 10News+

Cartherics is proud to share that our CEO, Professor Alan Trounson, was recently interviewed on 10 News+ by journalists Amelia Brace and Denham Hitchcock.

In the interview, Prof. Trounson provided an in-depth look at Cartherics’ world-first immunotherapies and how this innovative science is shaping the future of treatment for some of the most difficult-to-treat diseases.

Our lead […]

Christine Filippis2025-09-02T15:33:02+10:00September 2nd, 2025|

Cartherics Granted Chinese Patent for Enhancing Immune Cell Function

Cartherics Granted Chinese Patent for Enhancing Immune Cell Function

Melbourne, Australia, 27 August 2025 –  Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune cell therapies focusing on high-impact women’s diseases, with lead programs in ovarian cancer and endometriosis, today announced the granting of a patent for ‘Method for Providing Immune Cells with Enhanced Function’ by the Chinese Patent Office.

This […]

Christine Filippis2025-08-27T13:56:41+10:00August 27th, 2025|

Cartherics Unveils State-Of-The-Art Cleanroom Facility for Cell Therapy Manufacturing

Cartherics Unveils State-Of-The-Art Cleanroom Facility for Cell Therapy Manufacturing

Melbourne, Australia, 6 August 2025 –  Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune stem cell therapies focusing on high-impact women’s diseases, with lead programs in ovarian cancer and endometriosis, today unveiled its new, state-of-the-art cleanroom facility for clinical-scale manufacturing of cell therapy products.

The facility was officially opened by the […]

Christine Filippis2025-08-06T16:32:36+10:00August 6th, 2025|

About us

Sign up to our newsletter